Embo Molecular Medicine
(EMBO Mol Med) 《EMBO分子医学》
EMBO Molecular Medicine is an open access online journal published by Wiley-Blackwell on behalf of EMBO.
The quality of the journal is guaranteed by the editorial and advisory boards, consisting of leading researchers in the field of molecular medicine, together with the commitment to scientific excellence and the professionalism of EMBO Editors.
EMBO Molecular Medicine is a peer-reviewed, online open access journal dedicated to a new research discipline at the interface between clinical research and basic biology. It offers clinicians and researchers in this area the opportunity to publish their best work in a broadly distributed and highly visible forum, thereby lending a strong impetus to this important and rapidly developing field and helping to forge new links between clinicians and molecular biologists. Studies based on model organisms also fall within the scope of the journal, provided that the results presented are evidently and directly relevant to human disease.
EMBO Molecular Medicine publishes research articles as full-length research papers and short reports. In addition, the journal publishes editorials and review articles in innovative formats that target a broad and non-specialized audience.
Areas within the scope include, but are not limited to:
Differentiation and development
Genomics, transcriptomics, proteomics, metabolomics of disease, systems medicine
Immunology and inflammation
Neurodegeneration, neurological diseases and myopathies, sensory defects
Stem cells and regenerative medicine
Vascular and cardiovascular biology
- 2013-06-19•成人正常β细胞功能需要转录因子 GLIS3持续表达